Twist Bioscience CORP Form 4 insider transactions

Twist Bioscience CEO Emily M. Leproust sold 31,348 shares of common stock at $32.187 per share to cover tax withholding obligations related to PSU vesting.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 2,041 shares of common stock at $32.187 per share to cover tax withholding obligations.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 9,724 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience's President and COO, Patrick John Finn, sold 23,747 shares of common stock at $32.187 per share to cover tax withholding obligations related to vested Performance Stock Units.

Twist Bioscience Senior VP Dennis Cho sold 3,876 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 476 shares of common stock to cover tax withholding obligations related to Restricted Stock Unit vesting.

Twist Bioscience's Senior VP, Chief Legal Officer & Corporate Secretary, Dennis Cho, sold 124 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 140 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 206 shares of common stock to cover tax withholding obligations related to Restricted Stock Units.

A Twist Bioscience executive sold 233 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 295 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 1,704 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Twist Bioscience Senior VP Dennis Cho sold 94 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

A Twist Bioscience executive sold 269 shares of common stock at $25.76 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 892 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 2,265 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, reported a planned sale of 235 shares of common stock to cover tax withholding obligations.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 853 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 2,716 shares of common stock at $25.964 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 238 shares of common stock to cover tax withholding obligations related to RSU vesting.

Paula Green, SVP of Human Resources at Twist Bioscience, executed a non-discretionary sale of 619 common shares to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's CFO, Adam Laponis, sold 918 shares of common stock for $25.964 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's President and COO, Patrick John Finn, sold 1,840 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

A Twist Bioscience executive sold 521 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Twist Bioscience director Katryn Blake received a restricted stock unit award of 14,353 shares, vesting over three years.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 186 shares of common stock to cover tax withholding obligations related to RSU vesting.

Emily M. Leproust, CEO of Twist Bioscience, sold 5,585 shares to cover tax obligations related to vesting Restricted Stock Units.

Twist Bioscience's SVP of Human Resources sold 1,255 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Twist Bioscience's Chief Legal Officer, Dennis Cho, reported a pre-planned sale of 785 common shares at $28.364 per share, scheduled for August 4, 2025, to cover tax obligations from restricted stock unit vesting.

Twist Bioscience Corporation's President and COO, Patrick John Finn, sold 3,189 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.